Longping Bio Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 150

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Latest Deal Amount
  • $50.7M

  • Investors
  • 7

Longping Bio General Information

Description

Developer of agriculture biotechnology that develops transgenic traits of insect resistance and herbicide resistance of staple crops such as corn, soybean, and rice intended to promote the food security strategy of China. The company focuses on the transformation and optimization of insect-resistant genes, and combine the quality improvement traits of gene editing with the optimization of insect-resistant and herbicide-resistant traits, enabling producers and consumers to be benefited from their technologies.

Contact Information

Website
www.lpbt007.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 206, Building 3, Yabulun Industrial Park
  • Yazhou District
  • Sanya, Hainan 572025
  • China
+86 0898
Primary Industry
Agricultural Chemicals
Other Industries
Cultivation
Vertical(s)
Corporate Office
  • Room 206, Building 3, Yabulun Industrial Park
  • Yazhou District
  • Sanya, Hainan 572025
  • China
+86 0898

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Longping Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 30-Dec-2023 $50.7M Completed Generating Revenue
5. Later Stage VC (Series C) 27-Sep-2022 Completed Generating Revenue
4. Early Stage VC 25-Aug-2021 Completed Generating Revenue
3. Secondary Transaction - Private 11-Jun-2021 Completed Generating Revenue
2. Early Stage VC 11-Jun-2021 $22.2M $37.2M Completed Generating Revenue
1. Early Stage VC 09-Feb-2021 $15M $15M Completed Generating Revenue
To view Longping Bio’s complete valuation and funding history, request access »

Longping Bio Patents

Longping Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026152937-A1 Transgenic maize event lp007-21 and detection method therefor Pending 17-Jan-2025
WO-2025020707-A1 Transgenic soybean event lp086-1 and detection method therefor Inactive 25-Jul-2023
WO-2022053009-A1 Recombinant promoter, and gene expression cassette and application thereof in plant breeding Inactive 10-Sep-2020 C12N15/8238

Longping Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Longping Bio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Greater Bay Area Homeland Venture Capital Minority
Sanya Yazhou Bay Science and Technology City Holding Group Government Minority
Hosencare Brothers Growth/Expansion Minority
HSG (Hong Kong) Venture Capital Minority
SDIC Innovation Industry Fund Management Government Minority
You’re viewing 5 of 7 investors. Get the full list »

Longping Bio Investments (3)

Longping Bio’s most recent deal was a Later Stage VC with Green Fafa. The deal was made on 18-Aug-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Green Fafa 18-Aug-2023 Later Stage VC Cultivation
GeneWell 19-Oct-2022 Early Stage VC Diagnostic Equipment
Salus BioMed 18-Oct-2022 Early Stage VC Diagnostic Equipment
To view Longping Bio’s complete investments history, request access »

Longping Bio FAQs

  • When was Longping Bio founded?

    Longping Bio was founded in 2019.

  • Where is Longping Bio headquartered?

    Longping Bio is headquartered in Sanya, China.

  • What is the size of Longping Bio?

    Longping Bio has 150 total employees.

  • What industry is Longping Bio in?

    Longping Bio’s primary industry is Agricultural Chemicals.

  • Is Longping Bio a private or public company?

    Longping Bio is a Private company.

  • What is the current valuation of Longping Bio?

    The current valuation of Longping Bio is .

  • What is Longping Bio’s current revenue?

    The current revenue for Longping Bio is .

  • How much funding has Longping Bio raised over time?

    Longping Bio has raised $37.2M.

  • Who are Longping Bio’s investors?

    Greater Bay Area Homeland, Sanya Yazhou Bay Science and Technology City Holding Group, Hosencare Brothers, HSG (Hong Kong), and SDIC Innovation Industry Fund Management are 5 of 7 investors who have invested in Longping Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process